Navigating The New Normal: Life Sciences Real Estate in Europe — A Maturing Asset Class | Goodwin



There are many factors driving record levels of investment in the life sciences sector: an aging population, the convergence of scientific breakthroughs across different disciplines, national and regional government support and now, a global pandemic. In addition, the use of artificial intelligence and data is accelerating outcomes in this sector, which has witnessed many life sciences companies investing heavily in the recruitment and retention of “tech and data talent” across all levels (from graduates to senior executives), and often in competition with “Big Tech” firms. In turn, this growth is fueling demand for specialised real estate to meet the sector’s needs in key global locations.

Real estate participants are taking note, with life sciences seen as an industry with strong fundamentals that continue to strengthen in a post-pandemic world. Although life sciences real estate is more costly to…

Read more…